F
FENNEC PHARMACEUTICALS INC
NASDAQ: FENC (Fennec Pharmaceuticals Inc.)
Kemas kini terakhir: 2 jam lalu10.61
-0.01 (-0.14%)
| Penutupan Terdahulu | 10.62 |
| Jumlah Dagangan | 105,063 |
| Harga / Pendapatan (P/E Ke hadapan) | 10.57 |
| Harga / Jualan (P/S) | 5.94 |
| Harga / Buku (P/B) | 8.68 |
| Julat 52 Minggu |
| Margin Keuntungan | -46.71% |
| Margin Operasi (TTM) | -9.23% |
| EPS Cair (TTM) | -0.530 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -65.50% |
| Nisbah Semasa (MRQ) | 5.13 |
| Aliran Tunai Operasi (OCF TTM) | -16.39 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -9.65 M |
| Pulangan Atas Aset (ROA TTM) | -12.96% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Fennec Pharmaceuticals Inc. | Bercampur | Menaik |
AISkor Stockmoo
-0.5
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | -1.5 |
| Volatiliti Harga | -1.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | -0.50 |
|
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 16.29% |
| % Dimiliki oleh Institusi | 57.51% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Rosalind Advisors, Inc. | 30 Jun 2026 | 3,188,001 |
| Prospect Capital Advisors, Llc | 30 Jun 2026 | 497,800 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| BRUGHERA MARCO MARIA | - | 10.64 | -15,545 | -165,399 |
| Jumlah Keseluruhan Kuantiti Bersih | -15,545 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -165,399 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 10.64 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| BRUGHERA MARCO MARIA | Pengarah | 15 Sep 2026 | Jual automatik (-) | 15,545 | 10.64 | 165,399 |
| BRUGHERA MARCO MARIA | Pengarah | 15 Sep 2026 | Pelaksanaan pilihan | 15,545 | - | - |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |